Taking into account that CCNB2 was the only shared protein in the PBMCs of BC andknowing that mRNA expression level of CCNB2 was elevated in PBMCs of themetastatic BC patients, we introduce it as a diagnostic candidate biomarker in theprogression of BC patients using blood sampling. This evidence concerns the gene CCNB2 and breast cancer.